Carpenter Rick 4

What Happened

• Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care (TNDM), had restricted stock units (RSUs convert/vest) on Feb 17, 2026. The filing shows conversions/exercises of RSU-derived awards of 1,437 and 897 shares (total 2,334 shares). To cover tax withholding, the company withheld 808 and 504 shares (1,312 shares total) at $18.95 per share, generating a tax withholding value of about $24,863. No open-market sale was reported — the withheld shares were retained by the company to satisfy taxes.

Key Details

• Transaction date: 2026-02-17; Form 4 filed: 2026-02-19 (filed within typical two-business-day window).
• Reported conversions/exercises: 1,437 and 897 shares (total 2,334 shares converted from RSUs).
• Shares withheld for taxes (F): 808 shares ($15,312) and 504 shares ($9,551) = 1,312 shares withheld (~$24,863) at $18.95 per share.
• Transaction codes: M = exercise/conversion of derivative (RSU conversion); F = payment of exercise price or tax liability (withholding). No open-market sale proceeds to the insider.
• Shares owned after the reported transactions: not specified in the provided filing text.
• Footnotes: RSUs were granted under the 2023 Long‑Term Incentive Plan (awards dated 5/25/2023 and 5/23/2024). Each RSU converts to one share (or cash in lieu at the issuer's discretion). Vesting schedules: 33% on 5/15/2024 (for the 2023 award) and 33% on 5/15/2025 (for the 2024 award), with remaining shares vesting in equal quarterly installments.

Context

• This was a routine RSU vesting/conversion with shares withheld to satisfy tax obligations (a common, administrative action), not an open-market sale or purchase. For investors, withheld shares to meet tax liabilities generally do not signal bullish or bearish insider intent.